{
    "nct_id": "NCT05768282",
    "age": "Adults",
    "cancer_center_accrual_goal_upper": 0,
    "curated_on": "2023-03-14",
    "study_start_date": "2016-01-01",
    "study_completion_date": null,
    "data_table4": "Interventional",
    "drug_list": {
        "drug": [
            {
                "drug_name": "Drug: Oral prednisolone (30mg/day) for 28 days"
            }
        ]
    },
    "long_title": "Administration of Oral Prednisolone to Prevent Esophageal Stricture After Balloon-type Radiofrequency Ablation for Long-segment Esophageal Neoplasia",
    "last_updated": "2023-03-16",
    "management_group_list": {
        "management_group": [
            {
                "is_primary": "Y",
                "management_group_name": "Group1"
            }
        ]
    },
    "oncology_group_list": {
        "oncology_group": [
            {
                "group_name": "Group1",
                "is_primary": "N"
            }
        ]
    },
    "phase": "PHASE4",
    "principal_investigator": "NA",
    "principal_investigator_institution": "E-DA Hospital",
    "program_area_list": {
        "program_area": [
            {
                "is_primary": "Y",
                "program_area_name": "Program1"
            }
        ]
    },
    "protocol_id": 0,
    "protocol_ids": [],
    "protocol_no": "",
    "protocol_target_accrual": 50,
    "protocol_type": "INTERVENTIONAL",
    "prior_treatment_requirements": [
        "Inclusion Criteria:",
        "* Histology from endoscopic biopsies showed squamous intraepithelial neoplasia without stromal invasion;",
        "* No lymph node metastasis on endoscopic ultrasound or computed tomography;",
        "* Magnifying endoscopy showed the intraepithelial papillary capillary loop as type B1 pattern, according to the classification of the microvascular architecture of superficial esophageal carcinoma.",
        "Exclude - Exclusion Criteria:",
        "Exclude - * A prior history of endoscopic resection, radiation therapy or esophagectomy for esophageal cancer;",
        "Exclude - * A stricture that prevented the passage of a therapeutic endoscope;",
        "Exclude - * Uncontrolled coagulopathy;",
        "Exclude - * Poorly controlled diabetes mellitus."
    ],
    "short_title": "Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia",
    "site_list": {
        "site": []
    },
    "sponsor_list": {
        "sponsor": [
            {
                "is_principal_sponsor": "Y",
                "sponsor_name": "E-DA Hospital",
                "sponsor_protocol_no": "",
                "sponsor_roles": "sponsor"
            }
        ]
    },
    "staff_list": {
        "protocol_staff": []
    },
    "status": "open to accrual",
    "summary": "Endoscopic radiofrequency ablation (RFA) has shown good efficacy and safety in eradicating flat-type early esophageal squamous cell neoplasia (ESCN). However, post-RFA stricture is still a major concern, especially when treating long-segment early ESCNs. The aim of this study was to investigate the efficacy and safety of oral prednisolone to prevent post-RFA stricture.",
    "treatment_list": {
        "step": [
            {
                "step_internal_id": 111,
                "step_code": "1",
                "step_type": "Registration",
                "arm": [
                    {
                        "arm_code": "Administration of oral prednisolone",
                        "arm_internal_id": 0,
                        "arm_description": "Oral prednisolone start at a dose of 30 mg/day on the third day after RFA, and continue for 4 weeks.",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Oral prednisolone (30mg/day) for 28 days",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    }
                ],
                "match": [
                    {
                        "and": [
                            {
                                "or": [
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Esophageal Squamous Cell Carcinoma"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Mucosal Melanoma of the Esophagus"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Esophageal Poorly Differentiated Carcinoma"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Esophagogastric Adenocarcinoma"
                                        }
                                    }
                                ]
                            },
                            {
                                "clinical": {
                                    "age_numerical": ">=20",
                                    "disease_status": [
                                        "Early Stage"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            }
        ]
    }
}